Journal of Neuro-Oncology

02/06/2025

Gu et al. reveal that cabergoline treatment upregulates NDFIP1 in rat pituitary neuroendocrine tumor cells, offering a potential target to overcome dopamine agonist resistance in these patients.

Read more:https://link.springer.com/article/10.1007/s11060-025-04949-7

02/05/2025

*Editorial board member spotlight*

Hirokai Wakimoto leads a research group focused on oncolytic viruses and patient-derived stem like glioma models. We appreciate your contributions!

02/03/2025

This special issue celebrates 40 years of innovation in neurosurgical oncology with the AANS/CNS .


Read more:https://link.springer.com/article/10.1007/s11060-025-04941-1

02/02/2025

Umeda et al. revealed that higher pre-OP BMI and hypothalamic involvement in craniopharyngioma patients lead to an increased risk of post-OP obesity, and larger tumor size and recurrence reduce patients' social participation rates.

Read more:https://link.springer.com/article/10.1007/s11060-024-04925-7

02/01/2025

Journal of Neuro-Oncology has another exciting Tumor Talk coming up on February 10, 2025 at 4pm EST.

JNO's Tumor Talk--key opinion leaders sharing insights into their latest works in neuro-oncology

01/31/2025

Consider submitting your work to our special collection entitled: "Innovation and Emerging Treatment Strategies for High Grade Gliomas." Submissions are due by June 30th.

More information found here:

In this special collection of the Journal of Neuro-Oncology, we provide a comprehensive overview of recent advances in surgical resection of HGGs as well as ...

01/31/2025

Rosenstock et al. reported that navigated repetitive transcranial magnetic stimulation in brain tumor patients reduces transcallosal inhibition, with a notably low number needed to treat, particularly in cases caused by ischemia.

Read more:https://link.springer.com/article/10.1007/s11060-024-04931-9

01/22/2025

Nåhls et al. showed that early specialist palliative care contact significantly reduced outpatient clinic visits and hospitalizations in the final months of life for brain tumor patients.

Read more:https://link.springer.com/article/10.1007/s11060-025-04939-9

01/20/2025

Yakubov et al. provided excellent insights on how transcription factor dysregulation contributes to therapeutic resistance in GBM, focusing on the RTK/Ras/Raf/MEK/ERK signaling pathway.

Read more:https://link.springer.com/article/10.1007/s11060-024-04930-w

01/15/2025

Kite et al offer a perspective on the role of SRS in spinal metastases from primary prostate cancer originally written by

Read more:

Home Journal of Neuro-Oncology Article Comment on “Stereotactic radiosurgery for patients with spinal metastases from prostate cancer” Correspondence Published: 15 January 2025 (2025) Cite this article Journal of Neuro-Oncology Aims and scope Submit manuscript Trent Kite1, Rodney E. Wegner1,2 & ...

01/14/2025

We are pleased to present our third issue in the JNO of February 2025!

Read more: https://link.springer.com/journal/11060/volumes-and-issues/171-3

01/11/2025

Wach et al. reported the largest meta-analysis of pediatric meningiomas, addressing progression-free survival and overall survival and highlighting the roles of GTR and adjuvant radiotherapy in improving outcomes.

Read more:https://link.springer.com/article/10.1007/s11060-024-04917-7

01/09/2025

Narsinh et al demonstrated CED using liposomal irinotecan was feasible in 18 patients with recurrent high-grade glioma and PFS and OS were higher than expected for this patient population.

Read more: https://ow.ly/k0aE50UCRxU

01/06/2025

Randrian et al. , in the METACER study, showed that brain metastasizes from gastrointestinal cancers have a poor prognosis.

Read more:https://link.springer.com/article/10.1007/s11060-024-04905-x

01/05/2025

El-Hajj et al. reveal that pediatric patients with spinal chordomas often present with more advanced-stage tumors but achieve overall survival outcomes comparable to adults.

Read more:https://link.springer.com/article/10.1007/s11060-024-04921-x

01/03/2025

Editorial board member spotlight:

Dr. Kamran Ahmed is an Associate Vice Chair of Research . He is the PI of several multicenter trials in the management of brain metastases and leptomeningeal disease with novel therapeutics and radiation therapy.

01/03/2025

We are pleased to present our second of two issues in the JNO for January of 2025!

Read more: https://link.springer.com/journal/11060/volumes-and-issues/171-2

01/03/2025

Shoshan et al. reported the safety and feasibility of implementing alpha-emitter radiation therapy (Alpha-DaRT) in swine brains using image-guided stereotactic.

Read more:https://link.springer.com/article/10.1007/s11060-024-04919-5